Howard Tucker

650 total citations
19 papers, 509 citations indexed

About

Howard Tucker is a scholar working on Organic Chemistry, Molecular Biology and Spectroscopy. According to data from OpenAlex, Howard Tucker has authored 19 papers receiving a total of 509 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Organic Chemistry, 7 papers in Molecular Biology and 5 papers in Spectroscopy. Recurrent topics in Howard Tucker's work include Analytical Chemistry and Chromatography (4 papers), Asymmetric Synthesis and Catalysis (3 papers) and Inflammatory mediators and NSAID effects (3 papers). Howard Tucker is often cited by papers focused on Analytical Chemistry and Chromatography (4 papers), Asymmetric Synthesis and Catalysis (3 papers) and Inflammatory mediators and NSAID effects (3 papers). Howard Tucker collaborates with scholars based in United Kingdom. Howard Tucker's co-authors include B.J.A. Furr, B. Valcaccia, J.R. Woodburn, John S. Shaw, John G. Cumming, J.W. Oldfield, Jerry I. Hirsch, Ken Grime, Anne Cooper and David Whittaker and has published in prestigious journals such as New England Journal of Medicine, Journal of Medicinal Chemistry and The Journal of Organic Chemistry.

In The Last Decade

Howard Tucker

17 papers receiving 470 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Howard Tucker United Kingdom 11 158 156 137 111 108 19 509
Clémentine Féau United States 9 235 1.5× 112 0.7× 152 1.1× 77 0.7× 122 1.1× 13 469
Craig Marhefka United States 9 257 1.6× 262 1.7× 145 1.1× 87 0.8× 190 1.8× 10 598
Shuichi Furuya Japan 10 171 1.1× 107 0.7× 107 0.8× 169 1.5× 120 1.1× 14 570
N. Devleeschouwer Belgium 13 154 1.0× 45 0.3× 47 0.3× 61 0.5× 239 2.2× 30 453
Jerry R. Brooks United States 6 399 2.5× 210 1.3× 42 0.3× 249 2.2× 87 0.8× 8 679
C. David Jones United States 16 235 1.5× 208 1.3× 70 0.5× 316 2.8× 465 4.3× 28 985
Paul D. Colman United States 12 414 2.6× 68 0.4× 31 0.2× 47 0.4× 132 1.2× 21 625
Chong‐Qing Sun United States 10 164 1.0× 127 0.8× 51 0.4× 106 1.0× 75 0.7× 15 350
T. Arunachalam United States 14 340 2.2× 33 0.2× 59 0.4× 123 1.1× 129 1.2× 43 737
Achille Panzeri Italy 11 121 0.8× 105 0.7× 69 0.5× 79 0.7× 89 0.8× 18 327

Countries citing papers authored by Howard Tucker

Since Specialization
Citations

This map shows the geographic impact of Howard Tucker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Howard Tucker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Howard Tucker more than expected).

Fields of papers citing papers by Howard Tucker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Howard Tucker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Howard Tucker. The network helps show where Howard Tucker may publish in the future.

Co-authorship network of co-authors of Howard Tucker

This figure shows the co-authorship network connecting the top 25 collaborators of Howard Tucker. A scholar is included among the top collaborators of Howard Tucker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Howard Tucker. Howard Tucker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Cumming, John G., Howard Tucker, J.W. Oldfield, et al.. (2012). Balancing hERG affinity and absorption in the discovery of AZD5672, an orally active CCR5 antagonist for the treatment of rheumatoid arthritis. Bioorganic & Medicinal Chemistry Letters. 22(4). 1655–1659. 21 indexed citations
2.
Cumming, John G., S Brown, Anne Cooper, et al.. (2006). Modulators of the human CCR5 receptor. Part 3: SAR of substituted 1-[3-(4-methanesulfonylphenyl)-3-phenylpropyl]-piperidinyl phenylacetamides. Bioorganic & Medicinal Chemistry Letters. 16(13). 3533–3536. 15 indexed citations
3.
Cumming, John G., Anne Cooper, Ken Grime, et al.. (2005). Modulators of the human CCR5 receptor. Part 2: SAR of substituted 1-(3,3-diphenylpropyl)-piperidinyl phenylacetamides. Bioorganic & Medicinal Chemistry Letters. 15(22). 5012–5015. 21 indexed citations
4.
Furr, B.J.A. & Howard Tucker. (1996). The preclinical development of bicalutamide: pharmacodynamics and mechanism of action. Urology. 47(1). 13–25. 82 indexed citations
5.
Tucker, Howard, et al.. (1993). Novel inhibitors of prolyl 4-hydroxylase. Part 4 pyridine-2-carboxylic acid analogues with alternative 2-substituents. European Journal of Medicinal Chemistry. 28(6). 513–516. 21 indexed citations
6.
Tucker, Howard, et al.. (1992). Novel inhibitors of prolyl 4-hydroxylase. 2. 5-Amide substituted pyridine-2-carboxylic acids. Journal of Medicinal Chemistry. 35(5). 804–807. 20 indexed citations
7.
Tucker, Howard. (1990). Non-steroidal anti-androgens in the treatment of prostate cancer. Drugs of the Future. 15(3). 255–255. 5 indexed citations
9.
Tucker, Howard, et al.. (1988). Nonsteroidal antiandrogens. Synthesis and structure-activity relationships of 3-substituted derivatives of 2-hydroxypropionanilides. Journal of Medicinal Chemistry. 31(5). 954–959. 98 indexed citations
10.
Valcaccia, B., et al.. (1987). ICI 176,334: A NOVEL NON–STEROIDAL, PERIPHERALLY SELECTIVE ANTIANDROGEN. Journal of Endocrinology. 113(3). R7–R9. 98 indexed citations
11.
Tucker, Howard, et al.. (1985). 3 Recent Advances in β-Adrenergic Blocking Agents. Progress in medicinal chemistry. 22. 121–164. 18 indexed citations
12.
Tucker, Howard. (1981). .beta.-Adrenergic blocking agents. 21. Threo-1-(aryloxy)-3-(alkylamino)butan-2-ols. Journal of Medicinal Chemistry. 24(11). 1364–1368. 4 indexed citations
13.
Tucker, Howard. (1980). .beta.-Adrenergic blocking agents. 20. (3-Hydroxyprop-1-enyl)-substituted 1-(aryloxy)-3-(alkylamino)propan-2-ols. Journal of Medicinal Chemistry. 23(10). 1122–1126. 4 indexed citations
14.
Tucker, Howard. (1979). Stereospecific synthesis of threo- and erythro-1-(aryloxy)-3-(alkylamino)butan-2-ols. The Journal of Organic Chemistry. 44(16). 2943–2945. 18 indexed citations
15.
Tucker, Howard, et al.. (1978). .beta.-Adrenergic blocking agents. 18. 1-(Aryloxy)-3-(arylthioalkylamino)propan-2-ols and 1-substituted alkylthioamino-3-(aryloxy)propan-2-ols. Journal of Medicinal Chemistry. 21(8). 769–773. 10 indexed citations
16.
Smith, L. H. & Howard Tucker. (1977). .beta.-Adrenergic blocking agents. 17. 1-Phenoxy-3-phenoxyalkylamino-2-propanols and 1-alkoxyalkylamino-3-phenoxy-2-propanols. Journal of Medicinal Chemistry. 20(12). 1653–1656. 5 indexed citations
19.
Tucker, Howard & Jerry I. Hirsch. (1972). Sulfonamide-Sulfonylurea Interaction. New England Journal of Medicine. 286(2). 110–111. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026